The cyclooxygenase-2 inhibitor celecoxib effectively suppresses the development of non-melanoma skin cancers: results of a phase II/III clinical trial

被引：0
|
作者：
Elmets, C. A. [1 ]
Viner, J. L. [7 ]
Pentland, A. P. [9 ]
Cantrell, W. [1 ]
Bailey, H. [2 ]
Kang, S. [3 ]
Linden, K. G. [4 ]
Heffernan, M. [5 ]
Madeleine, D. [6 ]
Elewski, B. [1 ]
Umar, A. [7 ]
Lin, H. [1 ]
Bell, W. [1 ]
Gordon, G. [8 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Wisconsin, Madison, WI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Univ Calif Irvine, Irvine, CA USA
[5] Washington Univ, St Louis, MO USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] NCI, Bethesda, MD 20892 USA
[8] GD Searle Inc, Skokie, IL USA
[9] Univ Rochester, Rochester, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
325
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Prospective phase I/II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix
    Fyles, A
    Chan, P
    Milosevic, M
    Oza, A
    Syed, A
    Chin, S
    Pintiie, M
    Levin, M
    Manchul, L
    Doll, C
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S160 - S160
  • [2] Electronic brachytherapy for non-melanoma skin cancers: preliminary results of a pilot trial
    Maurizi, F.
    Capezzali, G.
    Mazza, M.
    Blasi, C.
    Moroni, G. L.
    La Macchia, M.
    Ciarmatori, A.
    Palleri, F.
    Argazzi, E.
    Giancaterino, S.
    Bono, M.
    Bunkheila, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S862 - S863
  • [3] Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities
    Goyal, Uma
    Cheung, Michael K.
    Suszko, Justin
    Laughlin, Brady
    Kim, Yongbok
    Askam, Jeanette
    Arif-Tiwari, Hina
    Slane, Benjamin
    Gordon, John
    Stea, Baldassare
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (05) : 497 - 503
  • [4] Daromun, a dermato-oncology drug in development for stage III and IV melanoma and non-melanoma skin cancers: A clinical overview
    Kahler, K. C.
    Zager, J. S.
    Elia, G.
    Neri, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S904 - S905
  • [5] Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
    Csiki, I
    Morrow, JD
    Sandler, A
    Shyr, Y
    Oates, J
    Williams, MK
    Dang, T
    Carbone, DP
    Johnson, DH
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6634 - 6640
  • [6] A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia
    Farley, John H.
    Truong, Vu
    Goo, Elwin
    Uyehara, Catherine
    Belnap, Christina
    Larsen, Wilma I.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 425 - 430
  • [7] A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
    Herrera, Fernanda G.
    Chan, Philip
    Doll, Corinne
    Milosevic, Michael
    Oza, Amit
    Syed, Amy
    Pintilie, Melania
    Levin, Wilfred
    Manchul, Lee
    Fyles, Anthony
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 97 - 103
  • [8] A prospective phase I/II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumour micro environment
    Herrera, F.
    Chan, A.
    Doll, C.
    Milosevic, M.
    Oza, A.
    Syed, A.
    Pintilie, M.
    Levin, W.
    Manchul, L.
    Fyles, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S65 - S66
  • [9] A prospective phase I/II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor micro environment
    Herrera, F
    Chan, P
    Milosevic, M
    Oza, A
    Syed, A
    Pintilie, M
    Levin, W
    Manchul, L
    Fyles, A
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S52 - S53
  • [10] Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases
    Leandro C. A. Cerchietti
    Marcelo R. Bonomi
    Alfredo H. Navigante
    Monica A. Castro
    Maria E. Cabalar
    Berta M. C. Roth
    Journal of Neuro-Oncology, 2005, 71 : 73 - 81
12345